Cargando…
Why pharmacokinetic differences among oral triptans have little clinical importance: a comment
Triptans, selective 5-HT1B/1D receptor agonists, are specific drugs for the acute treatment of migraine that have the same mechanism of action. Here, it is discussed why the differences among kinetic parameters of oral triptans have proved not to be very important in clinical practice. There are thr...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072488/ https://www.ncbi.nlm.nih.gov/pubmed/20878535 http://dx.doi.org/10.1007/s10194-010-0258-4 |
_version_ | 1782201561671270400 |
---|---|
author | Ferrari, Anna Tiraferri, Ilaria Neri, Laura Sternieri, Emilio |
author_facet | Ferrari, Anna Tiraferri, Ilaria Neri, Laura Sternieri, Emilio |
author_sort | Ferrari, Anna |
collection | PubMed |
description | Triptans, selective 5-HT1B/1D receptor agonists, are specific drugs for the acute treatment of migraine that have the same mechanism of action. Here, it is discussed why the differences among kinetic parameters of oral triptans have proved not to be very important in clinical practice. There are three main reasons: (1) the differences among the kinetic parameters of oral triptans are smaller than what appears from their average values; (2) there is a large inter-subject, gender-dependent, and intra-subject (outside/during the attack) variability of kinetic parameters related to the rate and extent of absorption, i.e., those which are considered as critical for the response; (3) no dose-concentration–response curves have been defined and it is, therefore, impossible both to compare the kinetics of triptans, and to verify the objective importance of kinetic differences; (4) the importance of kinetic differences is outweighed by non-kinetic factors of variability of response to triptans. If no oral formulations are found that can allow more predictable pharmacokinetics, the same problems will probably also arise with new classes of drugs for the acute treatment of migraine. |
format | Text |
id | pubmed-3072488 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Springer Milan |
record_format | MEDLINE/PubMed |
spelling | pubmed-30724882011-05-18 Why pharmacokinetic differences among oral triptans have little clinical importance: a comment Ferrari, Anna Tiraferri, Ilaria Neri, Laura Sternieri, Emilio J Headache Pain Review Article Triptans, selective 5-HT1B/1D receptor agonists, are specific drugs for the acute treatment of migraine that have the same mechanism of action. Here, it is discussed why the differences among kinetic parameters of oral triptans have proved not to be very important in clinical practice. There are three main reasons: (1) the differences among the kinetic parameters of oral triptans are smaller than what appears from their average values; (2) there is a large inter-subject, gender-dependent, and intra-subject (outside/during the attack) variability of kinetic parameters related to the rate and extent of absorption, i.e., those which are considered as critical for the response; (3) no dose-concentration–response curves have been defined and it is, therefore, impossible both to compare the kinetics of triptans, and to verify the objective importance of kinetic differences; (4) the importance of kinetic differences is outweighed by non-kinetic factors of variability of response to triptans. If no oral formulations are found that can allow more predictable pharmacokinetics, the same problems will probably also arise with new classes of drugs for the acute treatment of migraine. Springer Milan 2010-09-29 2011-02 /pmc/articles/PMC3072488/ /pubmed/20878535 http://dx.doi.org/10.1007/s10194-010-0258-4 Text en © Springer-Verlag 2010 |
spellingShingle | Review Article Ferrari, Anna Tiraferri, Ilaria Neri, Laura Sternieri, Emilio Why pharmacokinetic differences among oral triptans have little clinical importance: a comment |
title | Why pharmacokinetic differences among oral triptans have little clinical importance: a comment |
title_full | Why pharmacokinetic differences among oral triptans have little clinical importance: a comment |
title_fullStr | Why pharmacokinetic differences among oral triptans have little clinical importance: a comment |
title_full_unstemmed | Why pharmacokinetic differences among oral triptans have little clinical importance: a comment |
title_short | Why pharmacokinetic differences among oral triptans have little clinical importance: a comment |
title_sort | why pharmacokinetic differences among oral triptans have little clinical importance: a comment |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072488/ https://www.ncbi.nlm.nih.gov/pubmed/20878535 http://dx.doi.org/10.1007/s10194-010-0258-4 |
work_keys_str_mv | AT ferrarianna whypharmacokineticdifferencesamongoraltriptanshavelittleclinicalimportanceacomment AT tiraferriilaria whypharmacokineticdifferencesamongoraltriptanshavelittleclinicalimportanceacomment AT nerilaura whypharmacokineticdifferencesamongoraltriptanshavelittleclinicalimportanceacomment AT sternieriemilio whypharmacokineticdifferencesamongoraltriptanshavelittleclinicalimportanceacomment |